Literature DB >> 1489199

Increasing resistance of enterococci to ciprofloxacin.

D R Schaberg1, W I Dillon, M S Terpenning, K A Robinson, S F Bradley, C A Kauffman.   

Abstract

We determined that resistance to ciprofloxacin has emerged in enterococci over the last 5 years in our hospital, mainly in strains demonstrating the phenotype of high-level gentamicin resistance. All high-level-gentamicin-resistant isolates from 1985 and 1986 were susceptible, whereas 24% of isolates from 1989 and 1990 were resistant to ciprofloxacin. Plasmid and genomic DNA typing showed at least six unique strains exhibiting resistance, but one type accounted for 80% of recent resistant isolates, suggesting a role for cross infection in the emergence of resistance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489199      PMCID: PMC284368          DOI: 10.1128/AAC.36.11.2533

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites.

Authors:  B E Murray; K V Singh; J D Heath; B R Sharma; G M Weinstock
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics.

Authors:  D M Shlaes; B Binczewski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 3.  High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology.

Authors:  J E Patterson; M J Zervos
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

Review 4.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

5.  Enterococcal superinfection in patients treated with ciprofloxacin.

Authors:  M J Zervos; A E Bacon; J E Patterson; D R Schaberg; C A Kauffman
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

6.  Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.

Authors:  M J Kim; M Weiser; S Gottschall; E L Randall
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

7.  Increasing resistance of Staphylococcus aureus to ciprofloxacin.

Authors:  T E Daum; D R Schaberg; M S Terpenning; W S Sottile; C A Kauffman
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

8.  Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis.

Authors:  V D Wells; E S Wong; B E Murray; P E Coudron; D S Williams; S M Markowitz
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

9.  In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.

Authors:  D F Sahm; G T Koburov
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

10.  Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.

Authors:  S Schaefler
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

View more
  18 in total

Review 1.  The use of quinolones in developing countries.

Authors:  E Rodríguez-Noriega; R Morfin-Otero; S Esparza-Ahumada
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Survey of enterococcal susceptibility patterns in Belgium.

Authors:  P Vandamme; E Vercauteren; C Lammens; N Pensart; M Ieven; B Pot; R Leclercq; H Goossens
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.

Authors:  V Korten; J F Tomayko; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 5.  The epidemiology of bacterial resistance to quinolones.

Authors:  J F Acar; T F O'Brien; F W Goldstein; R N Jones
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Authors:  W V Kern; E Andriof; M Oethinger; P Kern; J Hacker; R Marre
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

7.  Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.

Authors:  F H van Tiel; B F Slangen; H C Schouten; J A Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

8.  In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.

Authors:  P French; E Venuti; H S Fraimow
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.

Authors:  G P Bongaerts; J A Hoogkamp-Korstanje
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Activity of clinafloxacin against multidrug-resistant Enterococcus faecium.

Authors:  S Burney; D Landman; J M Quale
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.